Molecular Analysis of Ozone Therapy Response in Women with Gynecological Tumors Experiencing Chronic Pelvic Pain After Cancer Treatment
Led by Bernardino Clavo, MD, PhD · Updated on 2026-09-25
40
Participants Needed
1
Research Sites
25 weeks
Total Duration
AI-Summary
What This Trial Is About
Gynecological cancers such as ovarian, uterine, and cervical cancers significantly impact womens health, particularly through chronic pelvic pain caused by treatments like radiotherapy and chemotherapy. This pain is often difficult to manage and can reduce quality of life. Researchers are studying how ozone therapy, a complementary treatment, affects gene expression and epigenetic changes to better understand its role in pain relief.
The study observes two groups of adult women with gynecological tumors treated by radiotherapy or chemotherapy those with chronic pelvic pain receiving compassionate ozone therapy and those without such pain. No experimental treatments are given as part of the study patients continue with their standard care. The research focuses on analyzing gene expression and biological age through epigenetic clocks before and after ozone therapy in the pain group, comparing these markers between the two groups.
Participants will be evaluated at the start and after 16 weeks, with assessments including gene expression, biological age markers, pain scores, quality of life questionnaires, toxicity grading, and biochemical markers of oxidative stress and inflammation. The study aims to link these molecular changes to clinical outcomes to better predict pain responses. The total study duration extends until August 2027, with ongoing monitoring of patient health and well-being throughout.
CONDITIONS
Brief Title
Gene and Molecular Pathways of Ozone Treatment Response in Gynecological Tumor Patients With Chronic Pelvic Pain Secondary to Cancer Treatment
Research Team
B
Bernardino Clavo, MD, PhD
F
Francisco Rodríguez-Esparragón, BSc, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Fundación Canaria Instituto de Investigación Sanitaria de Canarias
Collaborating Sponsor
Who Can Participate
Age: 18Years +
FEMALE
Eligibility Criteria
You may qualify if you...
Adult women (≥18 years old) with gynecological tumors treated with radiotherapy and chemotherapy.
Cancer disease is stable or in remission.
Life expectancy of 6 months or more.
For patients with pelvic pain: diagnosis confirming pain is not due to cancer.
For patients with pelvic pain: pain lasting 3 months or longer with intensity of 3 or higher on the Visual Analog Scale (VAS) or CTCAE Grade 2 or higher.
Signed and dated informed consent specific to this study.
You will not qualify if you...
Age under 18 years.
Severe psychiatric disorders.
Inability to complete quality of life questionnaires.
Active cancer requiring new systemic or local treatment started less than 3 months ago.
Life expectancy less than 6 months.
Failure to meet all inclusion criteria.
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Observation and Assessment
Duration - 16 weeks
Participants are observed and assessed for gene expression, biological age, pain levels, quality of life, and biochemical markers at the start and after 16 weeks. Those with chronic pelvic pain may receive compassionate ozone therapy as part of their care.
2 visits (baseline and week 16)
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Virtual Reality to Reduce Anxiety and Improve Patient Experience Before Gynecological Cancer Surgery in Women
A Randomized Controlled Trial Measuring Anxiety, Vital Signs, and Satisfaction
Development and Testing of the E-MOTE Artificial Intelligence Robot for Emotional Support in Newly Diagnosed Gynecologic Cancer Patients Undergoing Surgery
Phase II Trial of SPECT-Guided Functional Lung Avoidance Radiation Therapy
for Patients With Lung Cancer Receiving Curative Chemo-Radiotherapy
Molecular Analysis of Ozone Therapy Response in Women with Gynecological Tumors Experiencing Chronic Pelvic Pain After Cancer Treatment
Genetic Investigation of Chronic Prostatitis and Chronic Pelvic Pain Syndrome Including Related Bladder Conditions in Families in the USA and Canada
Relationship Between Kinesiophobia, Physical Activity, Sleep Quality, and Quality of Life in Women with Chronic Pelvic Pain
A Study Comparing Remote Pelvic Floor Yoga and Physical Conditioning for Women With Chronic Pelvic Pain Syndrome
Study of OxiblumeCoQ10 Ralivia Treatment for Men Aged 18-50 With Chronic ProstatitisChronic Pelvic Pain Syndrome in a Double-Blind Placebo-Controlled Trial
Phase 1 Study of Porphysome Nanoparticles for Imaging Safety and Distribution in Advanced Metastatic Gynecological Cancers
Long-Term Effects of Ozone Treatment in Patients with Persistent Numbness and Tingling Secondary to Chemotherapy-Induced Peripheral Neuropathy. A Retrospective Study.
Bernardino Clavo, Delvys Rodríguez-Abreu, Saray Galván-Ruiz...